{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:14:09Z","timestamp":1790104449096,"version":"4.0.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum rechts der Isar der Technischen Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Severe hypercapnia, especially when associated with acidosis, should be avoided or actively managed, as it is an independent risk factor in critically ill patients. The ADVOS multi hemodialysis system offers the potential to correct acidosis and hypercapnia through customizable pH and bicarbonate content within the dialysate fluid. The aim of this work is to analyze the exact timing for pH correction and the main factors leading to it in patients with multiple organ failure (MOF) and hypercapnic acidosis treated with ADVOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with MOF and metabolic or hypercapnic acidosis (pH\u2009&lt;\u20097.35) were included over a study period of 13\u00a0months. All patients received at least one treatment with ADVOS hemodialysis system for at least 24\u00a0h. The primary outcome was the time to blood pH\u2009\u2265\u20097.35.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      24 patients with a median age of 61\u00a0years and a median SOFA score of 15 points were included. The results of 134 ADVOS sessions, with a median of 5 sessions per patient, were analyzed. Median time to blood pH\u2009\u2265\u20097.35 was 4\u00a0h; a significant blood pH increase within 24\u00a0h was reached in all patients (7.21 before vs. 7.39 after,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A single session of ADVOS corrected blood pH and supported the reduction of pCO\n                      <jats:sub>2<\/jats:sub>\n                      with a median CO\n                      <jats:sub>2<\/jats:sub>\n                      removal of 55\u00a0mL\/min in patients with multiple organ failure and hypercapnic acidosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-025-00820-1","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:51:41Z","timestamp":1761367901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ADVanced Organ Support (ADVOS) hemodialysis system balances blood pH within 24\u00a0h in patients with multiple organ failure and hypercapnic acidosis"],"prefix":"10.1186","volume":"13","author":[{"given":"Miriam","family":"Dibos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritz Perez Ruiz","family":"de Garibay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland M.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Honigschnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-5311","authenticated-orcid":false,"given":"Tobias","family":"Lahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"820_CR1","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1097\/CCM.0000000000002332","volume":"45","author":"R Tiruvoipati","year":"2017","unstructured":"Tiruvoipati R, Pilcher D, Buscher H et al (2017) Effects of hypercapnia and hypercapnic acidosis on hospital mortality in mechanically ventilated patients. Crit Care Med 45:e649\u2013e656. https:\/\/doi.org\/10.1097\/CCM.0000000000002332","journal-title":"Crit Care Med"},{"key":"820_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.amjmed.2004.10.014","volume":"118","author":"DD Sin","year":"2005","unstructured":"Sin DD, Man SFP, Marrie TJ (2005) Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia. Am J Med 118:145\u2013150. https:\/\/doi.org\/10.1016\/j.amjmed.2004.10.014","journal-title":"Am J Med"},{"key":"820_CR3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00587170","volume":"347","author":"H Schaer","year":"1974","unstructured":"Schaer H (1974) Influence of respiratory and metabolic acidosis on epinephrine-inotropic effect in isolated guinea pig atria. Pflugers Arch 347:297\u2013307. https:\/\/doi.org\/10.1007\/BF00587170","journal-title":"Pflugers Arch"},{"key":"820_CR4","doi-asserted-by":"publisher","first-page":"H20","DOI":"10.1152\/ajpheart.1988.254.1.H20","volume":"254","author":"JD Marsh","year":"1988","unstructured":"Marsh JD, Margolis TI, Kim D (1988) Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 254:H20\u2013H27. https:\/\/doi.org\/10.1152\/ajpheart.1988.254.1.H20","journal-title":"Am J Physiol"},{"key":"820_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jama.2021.13374","volume":"326","author":"JJ McNamee","year":"2021","unstructured":"McNamee JJ, Gillies MA, Barrett NA et al (2021) Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial. JAMA 326:1013\u20131023. https:\/\/doi.org\/10.1001\/jama.2021.13374","journal-title":"JAMA"},{"key":"820_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113180","author":"B Csoma","year":"2022","unstructured":"Csoma B, Vulpi MR, Dragonieri S et al (2022) Hypercapnia in COPD: causes, consequences, and therapy. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11113180","journal-title":"J Clin Med"},{"key":"820_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/resp.13469","volume":"24","author":"V Comellini","year":"2019","unstructured":"Comellini V, Pacilli AMG, Nava S (2019) Benefits of non-invasive ventilation in acute hypercapnic respiratory failure. Respirology 24:308\u2013317. https:\/\/doi.org\/10.1111\/resp.13469","journal-title":"Respirology"},{"key":"820_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/03913988231191952","volume":"46","author":"O Sommerfeld","year":"2023","unstructured":"Sommerfeld O, Neumann C, Becker J et al (2023) Extracorporeal albumin dialysis in critically ill patients with liver failure: Comparison of four different devices-a retrospective analysis. Int J Artif Organs 46:481\u2013491. https:\/\/doi.org\/10.1177\/03913988231191952","journal-title":"Int J Artif Organs"},{"key":"820_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249342","volume":"16","author":"L Kaps","year":"2021","unstructured":"Kaps L, Ahlbrand CJ, Gadban R et al (2021) Applicability and safety of discontinuous ADVanced organ support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care. PLoS ONE 16:e0249342. https:\/\/doi.org\/10.1371\/journal.pone.0249342","journal-title":"PLoS ONE"},{"key":"820_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13533","author":"C Falkensteiner","year":"2020","unstructured":"Falkensteiner C, Kortgen A, Leonhardt J et al (2020) Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced organ support system in critically ill patients with liver failure\u2014a retrospective analysis. Ther Apher Dial. https:\/\/doi.org\/10.1111\/1744-9987.13533","journal-title":"Ther Apher Dial"},{"key":"820_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40635-017-0144-3","volume":"5","author":"A Al-Chalabi","year":"2017","unstructured":"Al-Chalabi A, Matevossian E, von Thaden A et al (2017) Evaluation of an ADVanced organ support (ADVOS) system in a two-hit porcine model of liver failure plus endotoxemia. Intensive Care Med Exp 5:31. https:\/\/doi.org\/10.1186\/s40635-017-0144-3","journal-title":"Intensive Care Med Exp"},{"key":"820_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12876-017-0569-x","volume":"17","author":"W Huber","year":"2017","unstructured":"Huber W, Henschel B, Schmid R et al (2017) First clinical experience in 14 patients treated with ADVOS: a study on feasibility, safety and efficacy of a new type of albumin dialysis. BMC Gastroenterol 17:32. https:\/\/doi.org\/10.1186\/s12876-017-0569-x","journal-title":"BMC Gastroenterol"},{"key":"820_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-83","volume":"13","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi A, Matevossian E, v Thaden A-K et al (2013) Evaluation of the Hepa wash\u00aetreatment in pigs with acute liver failure. BMC Gastroenterol 13:83. https:\/\/doi.org\/10.1186\/1471-230X-13-83","journal-title":"BMC Gastroenterol"},{"key":"820_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14044","author":"J Allescher","year":"2021","unstructured":"Allescher J, Rasch S, Wiessner JR et al (2021) Extracorporeal carbon dioxide removal (ECCO(2) R) with the Advanced Organ Support (ADVOS) system in critically ill COVID-19 patients. Artif Organs. https:\/\/doi.org\/10.1111\/aor.14044","journal-title":"Artif Organs"},{"key":"820_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13613-020-00714-3","volume":"10","author":"V Fuhrmann","year":"2020","unstructured":"Fuhrmann V, Weber T, Roedl K et al (2020) Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure. Ann Intensive Care 10:96. https:\/\/doi.org\/10.1186\/s13613-020-00714-3","journal-title":"Ann Intensive Care"},{"key":"820_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40635-019-0269-7","volume":"7","author":"P Ruiz","year":"2019","unstructured":"Ruiz P, de Garibay A, Kellum JA, Honigschnabel J et al (2019) Respiratory and metabolic acidosis correction with the ADVanced Organ Support system. Intensive Care Med Exp 7:56. https:\/\/doi.org\/10.1186\/s40635-019-0269-7","journal-title":"Intensive Care Med Exp"},{"key":"820_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14188","author":"M Acharya","year":"2022","unstructured":"Acharya M, Berger R, Popov A-F (2022) The role of the ADVanced organ support (ADVOS) system in critically ill patients with multiple organ failure. Artif Organs. https:\/\/doi.org\/10.1111\/aor.14188","journal-title":"Artif Organs"},{"key":"820_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1751143720915666","volume":"21","author":"R Tiruvoipati","year":"2020","unstructured":"Tiruvoipati R, Gupta S, Pilcher D et al (2020) Management of hypercapnia in critically ill mechanically ventilated patients-a narrative review of literature. J Intensive Care Soc 21:327\u2013333. https:\/\/doi.org\/10.1177\/1751143720915666","journal-title":"J Intensive Care Soc"},{"key":"820_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/cc10487","volume":"15","author":"B Jung","year":"2011","unstructured":"Jung B, Rimmele T, Le Goff C et al (2011) Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care 15:R238. https:\/\/doi.org\/10.1186\/cc10487","journal-title":"Crit Care"},{"key":"820_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40635-023-00563-x","volume":"11","author":"T Tonetti","year":"2023","unstructured":"Tonetti T, Zanella A, P\u00e9rez-Torres D et al (2023) Current knowledge gaps in extracorporeal respiratory support. Intensive Care Med Exp 11:77. https:\/\/doi.org\/10.1186\/s40635-023-00563-x","journal-title":"Intensive Care Med Exp"},{"key":"820_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","volume":"392","author":"S Jaber","year":"2018","unstructured":"Jaber S, Paugam C, Futier E et al (2018) Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial. Lancet 392:31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(18)31080-8","journal-title":"Lancet"},{"key":"820_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073487","volume":"13","author":"B Jung","year":"2023","unstructured":"Jung B, Huguet H, Molinari N et al (2023) Sodium bicarbonate for the treatment of severe metabolic acidosis with moderate or severe acute kidney injury in the critically ill: protocol for a randomised clinical trial (BICARICU-2). BMJ Open 13:e073487. https:\/\/doi.org\/10.1136\/bmjopen-2023-073487","journal-title":"BMJ Open"},{"key":"820_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04979-z","volume":"28","author":"JV Kunz","year":"2024","unstructured":"Kunz JV, Hansmann H, F\u00e4hndrich M et al (2024) Standard vs. carbone dioxide adapted kidney replacement therapy in hypercapnic ARDS patients: a randomized controlled pilot trial (BigBIC). Crit Care 28:198. https:\/\/doi.org\/10.1186\/s13054-024-04979-z","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00820-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00820-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T04:51:42Z","timestamp":1761367902000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00820-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00820-1","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"APR works at ADVITOS GmbH. TL received speaker\u2019s fees from ADVITOS. Other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}